Pacira reported $1.24B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Astellas Pharma JPY 2.56T 56.74B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
J&J USD 366.71B 32.94B Jun/2025
Ligand Pharmaceuticals USD 2.19B 168M Jun/2025
Novo Nordisk A/S 1.96T 370.19B Jun/2025
Pacira USD 1.11B 43M Jun/2025
Perrigo USD 3.65B 177M Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Supernus Pharmaceuticals USD 1.76B 65M Jun/2025
Teva Pharmaceutical Industries ILS 65.36B 1.34B Jun/2025
Xeris Pharmaceuticals USD 1.1B 347M Sep/2025
Zoetis USD 69.43B 4.01B Jun/2025